EMA works on new scheme to support drugs for unmet needs
This article was originally published in SRA
Executive Summary
The European Medicines Agency is developing a new scheme to provide better procedural support to drug sponsors that are developing drugs that have the potential to address unmet needs. The scheme is expected to be finalized and launched at the end of 2015.